Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
UBS
Medtronic
Cerilliant
Citi
Argus Health
Merck
Teva
Daiichi Sankyo

Generated: April 20, 2018

DrugPatentWatch Database Preview

CROTAN Drug Profile

« Back to Dashboard

When do Crotan patents expire, and when can generic versions of Crotan launch?

Crotan is a drug marketed by Marnel Pharms and is included in one NDA.

The generic ingredient in CROTAN is crotamiton. There are five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the crotamiton profile page.
Drug patent expirations by year for CROTAN
Synonyms for CROTAN
(2E)-N-ethyl-N-(2-methylphenyl)but-2-enamide
(E)-N-ethyl-N-(2-methylphenyl)-2-butenamide
(E)-N-ethyl-N-(2-methylphenyl)but-2-enamide
(E)-N-Ethyl-N-(o-tolyl)but-2-enamide
124236-29-9
2-Butenamide, N-ethyl-N-(2-methylphenyl)-
2-Butenamide, N-ethyl-N-(2-methylphenyl)-, (2E)-
2-Butenamide, N-ethyl-N-(2-methylphenyl)-, (E)-
2-Butenamide,N-ethyl-N-(2-methylphenyl)-
2EEH27851Y
3-12-00-01856 (Beilstein Handbook Reference)
483-63-6
483C636
A827519
AB00513973
AB00513973_10
AB00513973-09
AB2000238
AC1LEL5N
AC1Q2YLR
AC1Q5IA6
ACN-S001991
AI3-17732
AK307309
AKOS015892746
AS-11641
BBV-42867418
Bestloid
BPBio1_001038
BRD-K13240564-001-01-8
BRD-K57179821-001-05-5
BRN 3275497
BSPBio_000942
BSPBio_002722
Caswell No. 431B
CC-26001
CCG-39402
CHEBI:31439
CHEMBL1200709
component of Eurax (Salt/Mix)
CPD000059145
Crotalgin
Crotamitex
crotamiton
Crotamiton (JAN/USP/INN)
Crotamiton [INN:BAN:JAN]
Crotamiton, (E)-
Crotamiton, British Pharmacopoeia (BP) Reference Standard
Crotamiton, European Pharmacopoeia (EP) Reference Standard
Crotamiton, United States Pharmacopeia (USP) Reference Standard
Crotamitone
Crotamitonum
Crotamitonum [INN-Latin]
Crotonyl-N-ethyl-o-toluidine
CS-4730
D01381
D0T3NY
DNTGGZPQPQTDQF-XBXARRHUSA-N
DR000323
E0814
EINECS 207-596-3
EPA Pesticide Chemical Code 055701
Eurasil
Eurax
Eurax (TN)
Euraxil
G 7857
HMS1570P04
HMS1922P21
HMS2051E10
HMS2090A10
HMS2093O12
HMS2097P04
HMS2234E16
HY-B1177
I01-20166
I04-0177
InChI=1/C13H17NO/c1-4-8-13(15)14(5-2)12-10-7-6-9-11(12)3/h4,6-10H,5H2,1-3H3/b8-4
LS-55636
MFCD00026989
MLS000759489
MLS001424003
MLS002222307
MLS002695895
MolPort-001-794-624
N-Crotonyl-N-ethyl-o-toluidine
N-Ethyl- o-crotonotoluidide
N-Ethyl-N-(2-methylphenyl)-2-butenamide
N-Ethyl-N-(2-methylphenyl)-2-butenamide #
N-Ethyl-N-(2-methylphenyl)-butenamide
N-ethyl-N-(2-methylphenyl)but-2-enamide
N-ethyl-N-(o-tolyl)but-2-enamide
N-Ethyl-o-crotonotoluidide
N-Ethyl-o-crotonotoluidide, 97%
N-Ethyl-o-crotonotoluidine
N-Ethyl-ortho-crotonotoluidide
NC00107
NCGC00094571-01
NCGC00094571-02
NCGC00094571-03
NCGC00094571-04
NCGC00094571-05
NSC-758951
NSC-78382
NSC758951
NSC78382
o-CROTONOTOLUIDIDE, N-ETHYL-
OR136151
OR273107
Pharmakon1600-01505271
Prestwick2_000951
Prestwick3_000951
Q-200893
SAM001246702
SBB057407
SBI-0206763.P001
SC-15884
SC-89488
SCHEMBL32934
SMR000059145
SPECTRUM1505271
ST50409628
trans-Crotamiton
trans-N-Ethyl-N-(o-tolyl)-2-butenamide
UNII-2EEH27851Y
UNII-D6S4O4XD0H component DNTGGZPQPQTDQF-XBXARRHUSA-N
Veteusan
ZB001632
ZINC56427

US Patents and Regulatory Information for CROTAN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Marnel Pharms CROTAN crotamiton LOTION;TOPICAL 087204-001 Approved Prior to Jan 1, 1982 AT RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Harvard Business School
Mallinckrodt
Colorcon
Boehringer Ingelheim
Johnson and Johnson
UBS
Fuji
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.